ACM
IMNM icon

Aquatic Capital Management’s Immunome IMNM Stock Holding History

Aquatic Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86K Buy
+4,060
New +$86.9K ﹤0.01% 1113
2026
Q1 		– Sell
-31,323
Closed -$673K – 1591
2025
Q4 		$673K Buy
+31,323
New +$550K 0.02% 657
2025
Q1 		– Sell
-8,935
Closed -$94.9K – 1432
2024
Q4 		$94.9K Buy
+8,935
New +$108K ﹤0.01% 1078
2024
Q3 		– Sell
-30,400
Closed -$368K – 1337
2024
Q2 		$368K Buy
+30,400
New +$476K 0.01% 609

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Aquatic Capital Management's IMNM Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Immunome (IMNM) in Q2 2026: 4,060 shares worth $86K. The stake represents ﹤0.01% of the portfolio and ranks #1113 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in IMNM as recently as Q4 2025.

Aquatic Capital Management first reported a position in IMNM in Q2 2024 and has held it in 4 quarters since. The position peaked at $673K in Q4 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Aquatic Capital Management held 4,060 shares of Immunome worth $86K as of Q2 2026.
  • Immunome was a new Aquatic Capital Management position in Q2 2026.
  • Immunome made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1113 holding.
  • Aquatic Capital Management first reported a position in Immunome in Q2 2024 and has held it in 4 quarters since.
  • Aquatic Capital Management's Immunome position peaked at $673K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.